nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—CYP2B6—Raloxifene—osteoporosis	0.0469	0.0697	CbGbCtD
Lidocaine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0453	0.0673	CbGbCtD
Lidocaine—CYP1A2—Estropipate—osteoporosis	0.0412	0.0612	CbGbCtD
Lidocaine—CYP2C9—Estropipate—osteoporosis	0.0371	0.0551	CbGbCtD
Lidocaine—CYP2B6—Cholecalciferol—osteoporosis	0.0362	0.0538	CbGbCtD
Lidocaine—CYP2C8—Raloxifene—osteoporosis	0.0355	0.0528	CbGbCtD
Lidocaine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0343	0.051	CbGbCtD
Lidocaine—CYP3A7—Estradiol—osteoporosis	0.0306	0.0455	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0306	0.0455	CbGbCtD
Lidocaine—CYP2C8—Cholecalciferol—osteoporosis	0.0274	0.0407	CbGbCtD
Lidocaine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0232	0.0345	CbGbCtD
Lidocaine—CYP3A5—Estradiol—osteoporosis	0.023	0.0341	CbGbCtD
Lidocaine—CYP2C8—Estradiol—osteoporosis	0.0221	0.0328	CbGbCtD
Lidocaine—CYP3A4—Estropipate—osteoporosis	0.0216	0.0321	CbGbCtD
Lidocaine—CYP3A4—Calcitriol—osteoporosis	0.0216	0.0321	CbGbCtD
Lidocaine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0195	0.0289	CbGbCtD
Lidocaine—CYP2C9—Cholecalciferol—osteoporosis	0.0191	0.0284	CbGbCtD
Lidocaine—CYP2D6—Cholecalciferol—osteoporosis	0.0175	0.026	CbGbCtD
Lidocaine—CYP3A4—Ergocalciferol—osteoporosis	0.0172	0.0256	CbGbCtD
Lidocaine—CYP1A2—Estradiol—osteoporosis	0.0171	0.0254	CbGbCtD
Lidocaine—ABCB1—Conjugated Estrogens—osteoporosis	0.017	0.0253	CbGbCtD
Lidocaine—CYP2C9—Estradiol—osteoporosis	0.0154	0.0229	CbGbCtD
Lidocaine—ABCB1—Estradiol—osteoporosis	0.015	0.0222	CbGbCtD
Lidocaine—CYP3A4—Raloxifene—osteoporosis	0.0144	0.0214	CbGbCtD
Lidocaine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0139	0.0207	CbGbCtD
Lidocaine—CYP3A4—Cholecalciferol—osteoporosis	0.0111	0.0165	CbGbCtD
Lidocaine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0102	0.0152	CbGbCtD
Lidocaine—CYP3A4—Estradiol—osteoporosis	0.00896	0.0133	CbGbCtD
Lidocaine—Angioedema—Ethinyl Estradiol—osteoporosis	0.000368	0.00153	CcSEcCtD
Lidocaine—Sweating increased—Estradiol—osteoporosis	0.000368	0.00153	CcSEcCtD
Lidocaine—Tension—Pamidronate—osteoporosis	0.000367	0.00152	CcSEcCtD
Lidocaine—Eye disorder—Zoledronate—osteoporosis	0.000367	0.00152	CcSEcCtD
Lidocaine—Dysgeusia—Pamidronate—osteoporosis	0.000366	0.00152	CcSEcCtD
Lidocaine—Paraesthesia—Estropipate—osteoporosis	0.000365	0.00151	CcSEcCtD
Lidocaine—Flushing—Zoledronate—osteoporosis	0.000364	0.00151	CcSEcCtD
Lidocaine—Cardiac disorder—Zoledronate—osteoporosis	0.000364	0.00151	CcSEcCtD
Lidocaine—Visual impairment—Conjugated Estrogens—osteoporosis	0.000364	0.00151	CcSEcCtD
Lidocaine—Nervousness—Pamidronate—osteoporosis	0.000363	0.00151	CcSEcCtD
Lidocaine—Back pain—Pamidronate—osteoporosis	0.000362	0.0015	CcSEcCtD
Lidocaine—Somnolence—Estropipate—osteoporosis	0.000361	0.0015	CcSEcCtD
Lidocaine—Angioedema—Risedronate—osteoporosis	0.000359	0.00149	CcSEcCtD
Lidocaine—Angiopathy—Zoledronate—osteoporosis	0.000356	0.00148	CcSEcCtD
Lidocaine—Immune system disorder—Zoledronate—osteoporosis	0.000354	0.00147	CcSEcCtD
Lidocaine—Eye disorder—Conjugated Estrogens—osteoporosis	0.000353	0.00146	CcSEcCtD
Lidocaine—Chills—Zoledronate—osteoporosis	0.000352	0.00146	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Estropipate—osteoporosis	0.000351	0.00145	CcSEcCtD
Lidocaine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00035	0.00145	CcSEcCtD
Lidocaine—Paraesthesia—Ibandronate—osteoporosis	0.00035	0.00145	CcSEcCtD
Lidocaine—Pain—Estropipate—osteoporosis	0.000347	0.00144	CcSEcCtD
Lidocaine—Hypersensitivity—Etidronic acid—osteoporosis	0.000346	0.00143	CcSEcCtD
Lidocaine—Loss of consciousness—Risedronate—osteoporosis	0.000346	0.00143	CcSEcCtD
Lidocaine—Agitation—Pamidronate—osteoporosis	0.000343	0.00142	CcSEcCtD
Lidocaine—Angiopathy—Conjugated Estrogens—osteoporosis	0.000343	0.00142	CcSEcCtD
Lidocaine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000342	0.00142	CcSEcCtD
Lidocaine—Pain—Alendronate—osteoporosis	0.000342	0.00142	CcSEcCtD
Lidocaine—Angioedema—Pamidronate—osteoporosis	0.000342	0.00142	CcSEcCtD
Lidocaine—Erythema—Zoledronate—osteoporosis	0.000341	0.00142	CcSEcCtD
Lidocaine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000341	0.00141	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00034	0.00141	CcSEcCtD
Lidocaine—Hypertension—Risedronate—osteoporosis	0.000339	0.00141	CcSEcCtD
Lidocaine—Somnolence—Calcitriol—osteoporosis	0.000339	0.00141	CcSEcCtD
Lidocaine—Pain—Raloxifene—osteoporosis	0.000336	0.00139	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000336	0.00139	CcSEcCtD
Lidocaine—Chest pain—Risedronate—osteoporosis	0.000335	0.00139	CcSEcCtD
Lidocaine—Dysgeusia—Zoledronate—osteoporosis	0.000334	0.00139	CcSEcCtD
Lidocaine—Anxiety—Risedronate—osteoporosis	0.000334	0.00138	CcSEcCtD
Lidocaine—Pain—Ibandronate—osteoporosis	0.000333	0.00138	CcSEcCtD
Lidocaine—Back pain—Zoledronate—osteoporosis	0.00033	0.00137	CcSEcCtD
Lidocaine—Neuropathy peripheral—Estradiol—osteoporosis	0.00033	0.00137	CcSEcCtD
Lidocaine—Feeling abnormal—Alendronate—osteoporosis	0.00033	0.00137	CcSEcCtD
Lidocaine—Oedema—Ethinyl Estradiol—osteoporosis	0.000329	0.00137	CcSEcCtD
Lidocaine—Erythema—Conjugated Estrogens—osteoporosis	0.000329	0.00136	CcSEcCtD
Lidocaine—Loss of consciousness—Pamidronate—osteoporosis	0.000329	0.00136	CcSEcCtD
Lidocaine—Pain—Calcitriol—osteoporosis	0.000326	0.00135	CcSEcCtD
Lidocaine—Convulsion—Pamidronate—osteoporosis	0.000324	0.00134	CcSEcCtD
Lidocaine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000323	0.00134	CcSEcCtD
Lidocaine—Hypertension—Pamidronate—osteoporosis	0.000323	0.00134	CcSEcCtD
Lidocaine—Tension—Conjugated Estrogens—osteoporosis	0.000323	0.00134	CcSEcCtD
Lidocaine—Urticaria—Estropipate—osteoporosis	0.000323	0.00134	CcSEcCtD
Lidocaine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000322	0.00134	CcSEcCtD
Lidocaine—Vision blurred—Zoledronate—osteoporosis	0.000322	0.00133	CcSEcCtD
Lidocaine—Feeling abnormal—Ibandronate—osteoporosis	0.000321	0.00133	CcSEcCtD
Lidocaine—Tremor—Zoledronate—osteoporosis	0.00032	0.00133	CcSEcCtD
Lidocaine—Nervousness—Conjugated Estrogens—osteoporosis	0.000319	0.00132	CcSEcCtD
Lidocaine—Back pain—Conjugated Estrogens—osteoporosis	0.000318	0.00132	CcSEcCtD
Lidocaine—Urticaria—Alendronate—osteoporosis	0.000318	0.00132	CcSEcCtD
Lidocaine—Anxiety—Pamidronate—osteoporosis	0.000317	0.00132	CcSEcCtD
Lidocaine—Shock—Risedronate—osteoporosis	0.000316	0.00131	CcSEcCtD
Lidocaine—Nervous system disorder—Risedronate—osteoporosis	0.000315	0.00131	CcSEcCtD
Lidocaine—Agitation—Zoledronate—osteoporosis	0.000314	0.0013	CcSEcCtD
Lidocaine—Angioedema—Zoledronate—osteoporosis	0.000312	0.00129	CcSEcCtD
Lidocaine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00031	0.00128	CcSEcCtD
Lidocaine—Urticaria—Ibandronate—osteoporosis	0.000309	0.00128	CcSEcCtD
Lidocaine—Confusional state—Pamidronate—osteoporosis	0.000308	0.00128	CcSEcCtD
Lidocaine—Anaphylactic shock—Pamidronate—osteoporosis	0.000305	0.00127	CcSEcCtD
Lidocaine—Oedema—Pamidronate—osteoporosis	0.000305	0.00127	CcSEcCtD
Lidocaine—Haemoglobin—Estradiol—osteoporosis	0.000304	0.00126	CcSEcCtD
Lidocaine—Rhinitis—Estradiol—osteoporosis	0.000303	0.00126	CcSEcCtD
Lidocaine—Urticaria—Calcitriol—osteoporosis	0.000303	0.00126	CcSEcCtD
Lidocaine—Haemorrhage—Estradiol—osteoporosis	0.000302	0.00125	CcSEcCtD
Lidocaine—Hypoaesthesia—Estradiol—osteoporosis	0.000301	0.00125	CcSEcCtD
Lidocaine—Angioedema—Conjugated Estrogens—osteoporosis	0.0003	0.00125	CcSEcCtD
Lidocaine—Shock—Pamidronate—osteoporosis	0.0003	0.00124	CcSEcCtD
Lidocaine—Loss of consciousness—Zoledronate—osteoporosis	0.0003	0.00124	CcSEcCtD
Lidocaine—Hypersensitivity—Estropipate—osteoporosis	0.000299	0.00124	CcSEcCtD
Lidocaine—Nervous system disorder—Pamidronate—osteoporosis	0.000299	0.00124	CcSEcCtD
Lidocaine—Vomiting—Etidronic acid—osteoporosis	0.000298	0.00124	CcSEcCtD
Lidocaine—Rash—Etidronic acid—osteoporosis	0.000296	0.00123	CcSEcCtD
Lidocaine—Convulsion—Zoledronate—osteoporosis	0.000296	0.00123	CcSEcCtD
Lidocaine—Dermatitis—Etidronic acid—osteoporosis	0.000296	0.00123	CcSEcCtD
Lidocaine—Hyperhidrosis—Pamidronate—osteoporosis	0.000295	0.00122	CcSEcCtD
Lidocaine—Hypertension—Zoledronate—osteoporosis	0.000295	0.00122	CcSEcCtD
Lidocaine—Hypersensitivity—Alendronate—osteoporosis	0.000295	0.00122	CcSEcCtD
Lidocaine—Headache—Etidronic acid—osteoporosis	0.000294	0.00122	CcSEcCtD
Lidocaine—Asthenia—Estropipate—osteoporosis	0.000291	0.00121	CcSEcCtD
Lidocaine—Visual impairment—Estradiol—osteoporosis	0.000291	0.00121	CcSEcCtD
Lidocaine—Chest pain—Zoledronate—osteoporosis	0.000291	0.00121	CcSEcCtD
Lidocaine—Anxiety—Zoledronate—osteoporosis	0.00029	0.0012	CcSEcCtD
Lidocaine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000289	0.0012	CcSEcCtD
Lidocaine—Paraesthesia—Risedronate—osteoporosis	0.000288	0.0012	CcSEcCtD
Lidocaine—Asthenia—Alendronate—osteoporosis	0.000287	0.00119	CcSEcCtD
Lidocaine—Hypersensitivity—Ibandronate—osteoporosis	0.000287	0.00119	CcSEcCtD
Lidocaine—Dyspnoea—Risedronate—osteoporosis	0.000286	0.00119	CcSEcCtD
Lidocaine—Hypotension—Pamidronate—osteoporosis	0.000285	0.00118	CcSEcCtD
Lidocaine—Convulsion—Conjugated Estrogens—osteoporosis	0.000285	0.00118	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000284	0.00118	CcSEcCtD
Lidocaine—Eye disorder—Estradiol—osteoporosis	0.000282	0.00117	CcSEcCtD
Lidocaine—Tinnitus—Estradiol—osteoporosis	0.000282	0.00117	CcSEcCtD
Lidocaine—Confusional state—Zoledronate—osteoporosis	0.000281	0.00117	CcSEcCtD
Lidocaine—Hypersensitivity—Calcitriol—osteoporosis	0.000281	0.00116	CcSEcCtD
Lidocaine—Cardiac disorder—Estradiol—osteoporosis	0.000281	0.00116	CcSEcCtD
Lidocaine—Flushing—Estradiol—osteoporosis	0.000281	0.00116	CcSEcCtD
Lidocaine—Chest pain—Conjugated Estrogens—osteoporosis	0.00028	0.00116	CcSEcCtD
Lidocaine—Asthenia—Ibandronate—osteoporosis	0.000279	0.00116	CcSEcCtD
Lidocaine—Anxiety—Conjugated Estrogens—osteoporosis	0.000279	0.00116	CcSEcCtD
Lidocaine—Nausea—Etidronic acid—osteoporosis	0.000279	0.00116	CcSEcCtD
Lidocaine—Oedema—Zoledronate—osteoporosis	0.000279	0.00116	CcSEcCtD
Lidocaine—Anaphylactic shock—Zoledronate—osteoporosis	0.000279	0.00116	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000277	0.00115	CcSEcCtD
Lidocaine—Pain—Risedronate—osteoporosis	0.000274	0.00114	CcSEcCtD
Lidocaine—Angiopathy—Estradiol—osteoporosis	0.000274	0.00114	CcSEcCtD
Lidocaine—Shock—Zoledronate—osteoporosis	0.000274	0.00114	CcSEcCtD
Lidocaine—Paraesthesia—Pamidronate—osteoporosis	0.000274	0.00114	CcSEcCtD
Lidocaine—Asthenia—Calcitriol—osteoporosis	0.000273	0.00113	CcSEcCtD
Lidocaine—Nervous system disorder—Zoledronate—osteoporosis	0.000273	0.00113	CcSEcCtD
Lidocaine—Immune system disorder—Estradiol—osteoporosis	0.000273	0.00113	CcSEcCtD
Lidocaine—Dyspnoea—Pamidronate—osteoporosis	0.000272	0.00113	CcSEcCtD
Lidocaine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000271	0.00112	CcSEcCtD
Lidocaine—Chills—Estradiol—osteoporosis	0.000271	0.00112	CcSEcCtD
Lidocaine—Somnolence—Pamidronate—osteoporosis	0.000271	0.00112	CcSEcCtD
Lidocaine—Hyperhidrosis—Zoledronate—osteoporosis	0.000269	0.00112	CcSEcCtD
Lidocaine—Dizziness—Estropipate—osteoporosis	0.000269	0.00111	CcSEcCtD
Lidocaine—Oedema—Conjugated Estrogens—osteoporosis	0.000268	0.00111	CcSEcCtD
Lidocaine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000268	0.00111	CcSEcCtD
Lidocaine—Dizziness—Alendronate—osteoporosis	0.000264	0.0011	CcSEcCtD
Lidocaine—Shock—Conjugated Estrogens—osteoporosis	0.000264	0.00109	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000263	0.00109	CcSEcCtD
Lidocaine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000263	0.00109	CcSEcCtD
Lidocaine—Erythema—Estradiol—osteoporosis	0.000263	0.00109	CcSEcCtD
Lidocaine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000261	0.00108	CcSEcCtD
Lidocaine—Pain—Pamidronate—osteoporosis	0.000261	0.00108	CcSEcCtD
Lidocaine—Hypotension—Zoledronate—osteoporosis	0.00026	0.00108	CcSEcCtD
Lidocaine—Dizziness—Raloxifene—osteoporosis	0.00026	0.00108	CcSEcCtD
Lidocaine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000259	0.00108	CcSEcCtD
Lidocaine—Tension—Estradiol—osteoporosis	0.000258	0.00107	CcSEcCtD
Lidocaine—Vomiting—Estropipate—osteoporosis	0.000258	0.00107	CcSEcCtD
Lidocaine—Dysgeusia—Estradiol—osteoporosis	0.000258	0.00107	CcSEcCtD
Lidocaine—Dizziness—Ibandronate—osteoporosis	0.000257	0.00107	CcSEcCtD
Lidocaine—Rash—Estropipate—osteoporosis	0.000256	0.00106	CcSEcCtD
Lidocaine—Dermatitis—Estropipate—osteoporosis	0.000256	0.00106	CcSEcCtD
Lidocaine—Nervousness—Estradiol—osteoporosis	0.000256	0.00106	CcSEcCtD
Lidocaine—Urticaria—Risedronate—osteoporosis	0.000255	0.00106	CcSEcCtD
Lidocaine—Back pain—Estradiol—osteoporosis	0.000255	0.00106	CcSEcCtD
Lidocaine—Headache—Estropipate—osteoporosis	0.000254	0.00105	CcSEcCtD
Lidocaine—Vomiting—Alendronate—osteoporosis	0.000254	0.00105	CcSEcCtD
Lidocaine—Rash—Alendronate—osteoporosis	0.000252	0.00105	CcSEcCtD
Lidocaine—Dermatitis—Alendronate—osteoporosis	0.000252	0.00104	CcSEcCtD
Lidocaine—Feeling abnormal—Pamidronate—osteoporosis	0.000251	0.00104	CcSEcCtD
Lidocaine—Hypotension—Conjugated Estrogens—osteoporosis	0.000251	0.00104	CcSEcCtD
Lidocaine—Headache—Alendronate—osteoporosis	0.000251	0.00104	CcSEcCtD
Lidocaine—Paraesthesia—Zoledronate—osteoporosis	0.00025	0.00104	CcSEcCtD
Lidocaine—Vomiting—Raloxifene—osteoporosis	0.00025	0.00104	CcSEcCtD
Lidocaine—Dyspnoea—Zoledronate—osteoporosis	0.000248	0.00103	CcSEcCtD
Lidocaine—Rash—Raloxifene—osteoporosis	0.000248	0.00103	CcSEcCtD
Lidocaine—Dermatitis—Raloxifene—osteoporosis	0.000248	0.00103	CcSEcCtD
Lidocaine—Somnolence—Zoledronate—osteoporosis	0.000248	0.00103	CcSEcCtD
Lidocaine—Vomiting—Ibandronate—osteoporosis	0.000248	0.00103	CcSEcCtD
Lidocaine—Tremor—Estradiol—osteoporosis	0.000247	0.00102	CcSEcCtD
Lidocaine—Headache—Raloxifene—osteoporosis	0.000246	0.00102	CcSEcCtD
Lidocaine—Rash—Ibandronate—osteoporosis	0.000246	0.00102	CcSEcCtD
Lidocaine—Dermatitis—Ibandronate—osteoporosis	0.000245	0.00102	CcSEcCtD
Lidocaine—Headache—Ibandronate—osteoporosis	0.000244	0.00101	CcSEcCtD
Lidocaine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000242	0.00101	CcSEcCtD
Lidocaine—Vomiting—Calcitriol—osteoporosis	0.000242	0.00101	CcSEcCtD
Lidocaine—Agitation—Estradiol—osteoporosis	0.000242	0.001	CcSEcCtD
Lidocaine—Nausea—Estropipate—osteoporosis	0.000241	0.001	CcSEcCtD
Lidocaine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000241	0.000999	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000241	0.000998	CcSEcCtD
Lidocaine—Angioedema—Estradiol—osteoporosis	0.00024	0.000997	CcSEcCtD
Lidocaine—Rash—Calcitriol—osteoporosis	0.00024	0.000997	CcSEcCtD
Lidocaine—Dermatitis—Calcitriol—osteoporosis	0.00024	0.000996	CcSEcCtD
Lidocaine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000239	0.000992	CcSEcCtD
Lidocaine—Headache—Calcitriol—osteoporosis	0.000239	0.00099	CcSEcCtD
Lidocaine—Somnolence—Conjugated Estrogens—osteoporosis	0.000239	0.000989	CcSEcCtD
Lidocaine—Pain—Zoledronate—osteoporosis	0.000238	0.000988	CcSEcCtD
Lidocaine—Nausea—Alendronate—osteoporosis	0.000238	0.000985	CcSEcCtD
Lidocaine—Hypersensitivity—Risedronate—osteoporosis	0.000236	0.000981	CcSEcCtD
Lidocaine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000236	0.000979	CcSEcCtD
Lidocaine—Nausea—Raloxifene—osteoporosis	0.000234	0.000969	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000232	0.000961	CcSEcCtD
Lidocaine—Nausea—Ibandronate—osteoporosis	0.000231	0.000959	CcSEcCtD
Lidocaine—Loss of consciousness—Estradiol—osteoporosis	0.000231	0.000959	CcSEcCtD
Lidocaine—Asthenia—Risedronate—osteoporosis	0.00023	0.000955	CcSEcCtD
Lidocaine—Feeling abnormal—Zoledronate—osteoporosis	0.00023	0.000952	CcSEcCtD
Lidocaine—Pain—Conjugated Estrogens—osteoporosis	0.000229	0.000952	CcSEcCtD
Lidocaine—Hypertension—Estradiol—osteoporosis	0.000227	0.000942	CcSEcCtD
Lidocaine—Nausea—Calcitriol—osteoporosis	0.000226	0.000939	CcSEcCtD
Lidocaine—Hypersensitivity—Pamidronate—osteoporosis	0.000225	0.000932	CcSEcCtD
Lidocaine—Chest pain—Estradiol—osteoporosis	0.000224	0.000929	CcSEcCtD
Lidocaine—Anxiety—Estradiol—osteoporosis	0.000223	0.000926	CcSEcCtD
Lidocaine—Urticaria—Zoledronate—osteoporosis	0.000221	0.000918	CcSEcCtD
Lidocaine—Asthenia—Pamidronate—osteoporosis	0.000219	0.000908	CcSEcCtD
Lidocaine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000218	0.000903	CcSEcCtD
Lidocaine—Confusional state—Estradiol—osteoporosis	0.000217	0.000898	CcSEcCtD
Lidocaine—Oedema—Estradiol—osteoporosis	0.000215	0.000891	CcSEcCtD
Lidocaine—Anaphylactic shock—Estradiol—osteoporosis	0.000215	0.000891	CcSEcCtD
Lidocaine—Urticaria—Conjugated Estrogens—osteoporosis	0.000213	0.000884	CcSEcCtD
Lidocaine—Dizziness—Risedronate—osteoporosis	0.000212	0.00088	CcSEcCtD
Lidocaine—Shock—Estradiol—osteoporosis	0.000211	0.000876	CcSEcCtD
Lidocaine—Nervous system disorder—Estradiol—osteoporosis	0.000211	0.000873	CcSEcCtD
Lidocaine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000209	0.000868	CcSEcCtD
Lidocaine—Hyperhidrosis—Estradiol—osteoporosis	0.000208	0.000861	CcSEcCtD
Lidocaine—Rash—Ethinyl Estradiol—osteoporosis	0.000208	0.000861	CcSEcCtD
Lidocaine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000207	0.00086	CcSEcCtD
Lidocaine—Headache—Ethinyl Estradiol—osteoporosis	0.000206	0.000855	CcSEcCtD
Lidocaine—Hypersensitivity—Zoledronate—osteoporosis	0.000205	0.000851	CcSEcCtD
Lidocaine—Vomiting—Risedronate—osteoporosis	0.000204	0.000846	CcSEcCtD
Lidocaine—Rash—Risedronate—osteoporosis	0.000202	0.000839	CcSEcCtD
Lidocaine—Dermatitis—Risedronate—osteoporosis	0.000202	0.000838	CcSEcCtD
Lidocaine—Dizziness—Pamidronate—osteoporosis	0.000202	0.000837	CcSEcCtD
Lidocaine—Headache—Risedronate—osteoporosis	0.000201	0.000834	CcSEcCtD
Lidocaine—Asthenia—Zoledronate—osteoporosis	0.0002	0.000829	CcSEcCtD
Lidocaine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000198	0.00082	CcSEcCtD
Lidocaine—Nausea—Ethinyl Estradiol—osteoporosis	0.000195	0.000811	CcSEcCtD
Lidocaine—Vomiting—Pamidronate—osteoporosis	0.000194	0.000804	CcSEcCtD
Lidocaine—Paraesthesia—Estradiol—osteoporosis	0.000193	0.0008	CcSEcCtD
Lidocaine—Asthenia—Conjugated Estrogens—osteoporosis	0.000193	0.000798	CcSEcCtD
Lidocaine—Rash—Pamidronate—osteoporosis	0.000192	0.000798	CcSEcCtD
Lidocaine—Dermatitis—Pamidronate—osteoporosis	0.000192	0.000797	CcSEcCtD
Lidocaine—Dyspnoea—Estradiol—osteoporosis	0.000191	0.000794	CcSEcCtD
Lidocaine—Headache—Pamidronate—osteoporosis	0.000191	0.000793	CcSEcCtD
Lidocaine—Somnolence—Estradiol—osteoporosis	0.000191	0.000792	CcSEcCtD
Lidocaine—Nausea—Risedronate—osteoporosis	0.000191	0.000791	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000185	0.000769	CcSEcCtD
Lidocaine—Dizziness—Zoledronate—osteoporosis	0.000184	0.000764	CcSEcCtD
Lidocaine—Pain—Estradiol—osteoporosis	0.000184	0.000762	CcSEcCtD
Lidocaine—Nausea—Pamidronate—osteoporosis	0.000181	0.000751	CcSEcCtD
Lidocaine—Dizziness—Conjugated Estrogens—osteoporosis	0.000177	0.000736	CcSEcCtD
Lidocaine—Vomiting—Zoledronate—osteoporosis	0.000177	0.000735	CcSEcCtD
Lidocaine—Feeling abnormal—Estradiol—osteoporosis	0.000177	0.000734	CcSEcCtD
Lidocaine—Rash—Zoledronate—osteoporosis	0.000176	0.000729	CcSEcCtD
Lidocaine—Dermatitis—Zoledronate—osteoporosis	0.000176	0.000728	CcSEcCtD
Lidocaine—Headache—Zoledronate—osteoporosis	0.000175	0.000724	CcSEcCtD
Lidocaine—Vomiting—Conjugated Estrogens—osteoporosis	0.000171	0.000708	CcSEcCtD
Lidocaine—Urticaria—Estradiol—osteoporosis	0.000171	0.000707	CcSEcCtD
Lidocaine—Rash—Conjugated Estrogens—osteoporosis	0.000169	0.000702	CcSEcCtD
Lidocaine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000169	0.000701	CcSEcCtD
Lidocaine—Headache—Conjugated Estrogens—osteoporosis	0.000168	0.000697	CcSEcCtD
Lidocaine—Nausea—Zoledronate—osteoporosis	0.000166	0.000686	CcSEcCtD
Lidocaine—Nausea—Conjugated Estrogens—osteoporosis	0.000159	0.000661	CcSEcCtD
Lidocaine—Hypersensitivity—Estradiol—osteoporosis	0.000158	0.000656	CcSEcCtD
Lidocaine—Asthenia—Estradiol—osteoporosis	0.000154	0.000639	CcSEcCtD
Lidocaine—Dizziness—Estradiol—osteoporosis	0.000142	0.000589	CcSEcCtD
Lidocaine—Vomiting—Estradiol—osteoporosis	0.000137	0.000566	CcSEcCtD
Lidocaine—Rash—Estradiol—osteoporosis	0.000135	0.000562	CcSEcCtD
Lidocaine—Dermatitis—Estradiol—osteoporosis	0.000135	0.000561	CcSEcCtD
Lidocaine—Headache—Estradiol—osteoporosis	0.000135	0.000558	CcSEcCtD
Lidocaine—Nausea—Estradiol—osteoporosis	0.000128	0.000529	CcSEcCtD
Lidocaine—CYP2C8—Metabolism—MGLL—osteoporosis	2.72e-05	0.000315	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—P4HB—osteoporosis	2.7e-05	0.000314	CbGpPWpGaD
Lidocaine—EGFR—Disease—CALCA—osteoporosis	2.7e-05	0.000313	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ATIC—osteoporosis	2.69e-05	0.000312	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PNP—osteoporosis	2.69e-05	0.000312	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ATIC—osteoporosis	2.67e-05	0.00031	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PNP—osteoporosis	2.67e-05	0.00031	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—IDH2—osteoporosis	2.67e-05	0.00031	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—P4HB—osteoporosis	2.67e-05	0.000309	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KL—osteoporosis	2.66e-05	0.000308	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GAPDH—osteoporosis	2.65e-05	0.000308	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—FDPS—osteoporosis	2.63e-05	0.000305	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PKM—osteoporosis	2.63e-05	0.000305	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TGFB1—osteoporosis	2.62e-05	0.000304	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—IRS1—osteoporosis	2.62e-05	0.000304	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	2.6e-05	0.000302	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTH—osteoporosis	2.59e-05	0.000301	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—RAP1A—osteoporosis	2.58e-05	0.0003	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP27A1—osteoporosis	2.57e-05	0.000298	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—IL6R—osteoporosis	2.56e-05	0.000298	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.56e-05	0.000297	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RAP1A—osteoporosis	2.55e-05	0.000296	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CNR2—osteoporosis	2.53e-05	0.000293	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.52e-05	0.000292	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.51e-05	0.000291	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ACP5—osteoporosis	2.5e-05	0.00029	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PGLS—osteoporosis	2.49e-05	0.000289	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GPD2—osteoporosis	2.49e-05	0.000289	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NFATC1—osteoporosis	2.49e-05	0.000288	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—DKK1—osteoporosis	2.47e-05	0.000286	CbGpPWpGaD
Lidocaine—EGFR—Disease—KL—osteoporosis	2.45e-05	0.000285	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TNF—osteoporosis	2.45e-05	0.000284	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ACP5—osteoporosis	2.44e-05	0.000283	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—OXCT1—osteoporosis	2.43e-05	0.000282	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CA2—osteoporosis	2.43e-05	0.000282	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—WNT1—osteoporosis	2.38e-05	0.000276	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MGLL—osteoporosis	2.37e-05	0.000275	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—TPI1—osteoporosis	2.32e-05	0.000269	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGA—osteoporosis	2.31e-05	0.000268	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—IDH2—osteoporosis	2.31e-05	0.000268	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CA2—osteoporosis	2.29e-05	0.000266	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—OXCT1—osteoporosis	2.29e-05	0.000266	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ATIC—osteoporosis	2.28e-05	0.000265	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PNP—osteoporosis	2.28e-05	0.000265	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ENO1—osteoporosis	2.28e-05	0.000265	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—ADCY5—osteoporosis	2.28e-05	0.000264	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—OXCT1—osteoporosis	2.27e-05	0.000263	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CA2—osteoporosis	2.27e-05	0.000263	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—TPI1—osteoporosis	2.27e-05	0.000263	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PSMA5—osteoporosis	2.25e-05	0.000261	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PSMA2—osteoporosis	2.25e-05	0.000261	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ADCY5—osteoporosis	2.24e-05	0.00026	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GPX1—osteoporosis	2.23e-05	0.000259	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MGLL—osteoporosis	2.23e-05	0.000259	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MGLL—osteoporosis	2.21e-05	0.000257	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—P4HB—osteoporosis	2.18e-05	0.000253	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.17e-05	0.000252	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.15e-05	0.00025	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTHLH—osteoporosis	2.15e-05	0.000249	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—BMP2—osteoporosis	2.15e-05	0.000249	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GAPDH—osteoporosis	2.14e-05	0.000248	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—P4HB—osteoporosis	2.13e-05	0.000247	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ACP5—osteoporosis	2.11e-05	0.000245	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGB—osteoporosis	2.1e-05	0.000244	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GAPDH—osteoporosis	2.09e-05	0.000243	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ENO1—osteoporosis	2.09e-05	0.000242	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AGER—osteoporosis	2.09e-05	0.000242	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.09e-05	0.000242	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—RAP1A—osteoporosis	2.09e-05	0.000242	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.09e-05	0.000242	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ADCY5—osteoporosis	2.08e-05	0.000242	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—MTHFR—osteoporosis	2.06e-05	0.000239	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PSMA5—osteoporosis	2.06e-05	0.000239	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PSMA2—osteoporosis	2.06e-05	0.000239	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—RAP1A—osteoporosis	2.04e-05	0.000237	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PKM—osteoporosis	2.03e-05	0.000236	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—FDPS—osteoporosis	2.03e-05	0.000236	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PSMA2—osteoporosis	2.03e-05	0.000236	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PSMA5—osteoporosis	2.03e-05	0.000236	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—IDH2—osteoporosis	2.01e-05	0.000234	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—IL6—osteoporosis	2e-05	0.000232	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—IL6—osteoporosis	1.97e-05	0.000229	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—TPI1—osteoporosis	1.96e-05	0.000228	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—OXCT1—osteoporosis	1.94e-05	0.000225	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CA2—osteoporosis	1.94e-05	0.000225	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PGLS—osteoporosis	1.92e-05	0.000223	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GPD2—osteoporosis	1.92e-05	0.000223	CbGpPWpGaD
Lidocaine—EGFR—Disease—ADCY5—osteoporosis	1.92e-05	0.000223	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—IDH2—osteoporosis	1.9e-05	0.00022	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP27A1—osteoporosis	1.89e-05	0.00022	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CALCA—osteoporosis	1.89e-05	0.00022	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MGLL—osteoporosis	1.89e-05	0.000219	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—IDH2—osteoporosis	1.88e-05	0.000218	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.86e-05	0.000215	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.85e-05	0.000215	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—P4HB—osteoporosis	1.85e-05	0.000214	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ACP5—osteoporosis	1.84e-05	0.000214	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.82e-05	0.000211	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IRS2—osteoporosis	1.82e-05	0.000211	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GAPDH—osteoporosis	1.81e-05	0.00021	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—IL6—osteoporosis	1.81e-05	0.00021	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.78e-05	0.000207	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.78e-05	0.000207	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.77e-05	0.000205	CbGpPWpGaD
Lidocaine—EGFR—Disease—MTHFR—osteoporosis	1.77e-05	0.000205	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—RAP1A—osteoporosis	1.77e-05	0.000205	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PNP—osteoporosis	1.76e-05	0.000204	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ATIC—osteoporosis	1.76e-05	0.000204	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ACP5—osteoporosis	1.73e-05	0.000201	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.73e-05	0.000201	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.73e-05	0.000201	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ACP5—osteoporosis	1.72e-05	0.0002	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KL—osteoporosis	1.72e-05	0.000199	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TGFB1—osteoporosis	1.72e-05	0.000199	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—TPI1—osteoporosis	1.71e-05	0.000199	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.7e-05	0.000197	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ENO1—osteoporosis	1.69e-05	0.000196	CbGpPWpGaD
Lidocaine—EGFR—Disease—IRS2—osteoporosis	1.68e-05	0.000195	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—POMC—osteoporosis	1.68e-05	0.000194	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.67e-05	0.000194	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PSMA2—osteoporosis	1.66e-05	0.000193	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PSMA5—osteoporosis	1.66e-05	0.000193	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ENO1—osteoporosis	1.65e-05	0.000191	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—POMC—osteoporosis	1.65e-05	0.000191	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6R—osteoporosis	1.63e-05	0.00019	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PSMA2—osteoporosis	1.62e-05	0.000188	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PSMA5—osteoporosis	1.62e-05	0.000188	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—TPI1—osteoporosis	1.61e-05	0.000187	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—P4HB—osteoporosis	1.61e-05	0.000187	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—IDH2—osteoporosis	1.61e-05	0.000186	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TNF—osteoporosis	1.6e-05	0.000186	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—TPI1—osteoporosis	1.6e-05	0.000186	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IRS1—osteoporosis	1.59e-05	0.000184	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GAPDH—osteoporosis	1.58e-05	0.000183	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.54e-05	0.000179	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—RAP1A—osteoporosis	1.54e-05	0.000179	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—P4HB—osteoporosis	1.52e-05	0.000176	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.51e-05	0.000175	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—P4HB—osteoporosis	1.5e-05	0.000174	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CA2—osteoporosis	1.5e-05	0.000174	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.5e-05	0.000174	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6R—osteoporosis	1.49e-05	0.000173	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ADCY5—osteoporosis	1.49e-05	0.000173	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.49e-05	0.000173	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GPX1—osteoporosis	1.48e-05	0.000172	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.48e-05	0.000171	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ACP5—osteoporosis	1.47e-05	0.000171	CbGpPWpGaD
Lidocaine—EGFR—Disease—IRS1—osteoporosis	1.47e-05	0.00017	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MGLL—osteoporosis	1.46e-05	0.000169	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.45e-05	0.000168	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.45e-05	0.000168	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.44e-05	0.000167	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ENO1—osteoporosis	1.43e-05	0.000166	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PSMA5—osteoporosis	1.41e-05	0.000163	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PSMA2—osteoporosis	1.41e-05	0.000163	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6R—osteoporosis	1.38e-05	0.00016	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—MTHFR—osteoporosis	1.37e-05	0.000159	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TPI1—osteoporosis	1.37e-05	0.000159	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ADCY5—osteoporosis	1.36e-05	0.000158	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GPX1—osteoporosis	1.36e-05	0.000158	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.35e-05	0.000156	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ADCY5—osteoporosis	1.35e-05	0.000156	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.32e-05	0.000153	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SPP1—osteoporosis	1.3e-05	0.000151	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—IL6—osteoporosis	1.29e-05	0.00015	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—P4HB—osteoporosis	1.28e-05	0.000149	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GAPDH—osteoporosis	1.26e-05	0.000146	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—MTHFR—osteoporosis	1.26e-05	0.000146	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.25e-05	0.000145	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ENO1—osteoporosis	1.24e-05	0.000144	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—IDH2—osteoporosis	1.24e-05	0.000144	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.23e-05	0.000143	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PSMA2—osteoporosis	1.23e-05	0.000142	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PSMA5—osteoporosis	1.23e-05	0.000142	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IRS2—osteoporosis	1.18e-05	0.000137	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ENO1—osteoporosis	1.17e-05	0.000136	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.17e-05	0.000135	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ENO1—osteoporosis	1.16e-05	0.000135	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.15e-05	0.000134	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.15e-05	0.000134	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—LEP—osteoporosis	1.15e-05	0.000134	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.14e-05	0.000133	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.14e-05	0.000133	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—IL6—osteoporosis	1.14e-05	0.000133	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.14e-05	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL1B—osteoporosis	1.14e-05	0.000132	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ACP5—osteoporosis	1.13e-05	0.000132	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ADCY5—osteoporosis	1.1e-05	0.000128	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ESR1—osteoporosis	1.1e-05	0.000128	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GPX1—osteoporosis	1.1e-05	0.000127	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—POMC—osteoporosis	1.1e-05	0.000127	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ADCY5—osteoporosis	1.08e-05	0.000125	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GPX1—osteoporosis	1.07e-05	0.000124	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.07e-05	0.000124	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TPI1—osteoporosis	1.05e-05	0.000122	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IRS1—osteoporosis	1.03e-05	0.000119	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—MTHFR—osteoporosis	1.01e-05	0.000118	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—POMC—osteoporosis	1e-05	0.000116	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP19A1—osteoporosis	9.94e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ENO1—osteoporosis	9.93e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—P4HB—osteoporosis	9.91e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—MTHFR—osteoporosis	9.9e-06	0.000115	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—POMC—osteoporosis	9.9e-06	0.000115	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PSMA2—osteoporosis	9.78e-06	0.000114	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PSMA5—osteoporosis	9.78e-06	0.000114	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GAPDH—osteoporosis	9.73e-06	0.000113	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6R—osteoporosis	9.65e-06	0.000112	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF1—osteoporosis	9.52e-06	0.00011	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—RAP1A—osteoporosis	9.48e-06	0.00011	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.37e-06	0.000109	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ADCY5—osteoporosis	9.32e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GPX1—osteoporosis	9.29e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP19A1—osteoporosis	9.29e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MTHFR—osteoporosis	8.57e-06	9.95e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—osteoporosis	8.17e-06	9.48e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—osteoporosis	8.15e-06	9.46e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ADCY5—osteoporosis	8.12e-06	9.43e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—POMC—osteoporosis	8.1e-06	9.4e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GPX1—osteoporosis	8.09e-06	9.39e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.94e-06	9.21e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—POMC—osteoporosis	7.92e-06	9.19e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ENO1—osteoporosis	7.66e-06	8.89e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ADCY5—osteoporosis	7.65e-06	8.88e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GPX1—osteoporosis	7.63e-06	8.85e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ADCY5—osteoporosis	7.59e-06	8.81e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GPX1—osteoporosis	7.56e-06	8.77e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PSMA2—osteoporosis	7.55e-06	8.76e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PSMA5—osteoporosis	7.55e-06	8.76e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MTHFR—osteoporosis	7.47e-06	8.67e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—osteoporosis	7.28e-06	8.45e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MTHFR—osteoporosis	7.04e-06	8.17e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MTHFR—osteoporosis	6.98e-06	8.1e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—POMC—osteoporosis	6.86e-06	7.96e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—osteoporosis	6.65e-06	7.72e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ADCY5—osteoporosis	6.48e-06	7.52e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GPX1—osteoporosis	6.46e-06	7.5e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—osteoporosis	6.14e-06	7.13e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.12e-06	7.11e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—POMC—osteoporosis	5.97e-06	6.93e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MTHFR—osteoporosis	5.96e-06	6.92e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—osteoporosis	5.72e-06	6.64e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—osteoporosis	5.71e-06	6.62e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—POMC—osteoporosis	5.63e-06	6.53e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—POMC—osteoporosis	5.58e-06	6.48e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADCY5—osteoporosis	5e-06	5.81e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GPX1—osteoporosis	4.99e-06	5.79e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—POMC—osteoporosis	4.77e-06	5.53e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTHFR—osteoporosis	4.6e-06	5.34e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—osteoporosis	4.3e-06	4.99e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—POMC—osteoporosis	3.68e-06	4.27e-05	CbGpPWpGaD
